Invalid date chosen. Displaying data for the latest date instead.

Diabetes Mellitus Stocks List

Diabetes Mellitus Stocks Recent News

Date Stock Title
May 17 TNDM Tandem Diabetes (TNDM) Hits 52-Week High: What's Driving It?
May 17 DXCM Reasons to Retain DexCom (DXCM) Stock in Your Portfolio Now
May 16 DXCM Insider Sale: EVP Strategy and Corporate Development Matthew Dolan Sells Shares of DexCom Inc (DXCM)
May 16 HALO Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
May 16 RZLT Rezolute reports Q3 results
May 16 HALO Here's Why Halozyme Therapeutics (HALO) is a Strong Growth Stock
May 16 PODD Dexcom details plans for over-the-counter CGM as insulin pump firms seek Type 2 coverage
May 16 RSLS Reshape Lifesciences Inc (RSLS) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 15 RSLS ReShape Lifesciences reports Q1 results
May 15 RZLT Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business Update
May 15 RSLS ReShape Lifesciences® Reports First Quarter Ended March 31, 2024 Financial Results and Provides Corporate Update
May 15 DXCM Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
May 15 SENS Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
May 14 PODD Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market
May 14 PODD Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday?
May 14 DXCM Frank Sands' Strategic Moves in Q1 2024: A Closer Look at DexCom Inc's Portfolio Impact
May 14 RSLS ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update
May 14 SENS Senseonics Holdings Inc (SENS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
May 13 SENS Senseonics Holdings, Inc. (SENS) Q1 2024 Earnings Call Transcript
May 13 SENS Mercy to use Senseonics Eversense RPM to monitor diabetic patients
Diabetes Mellitus

Diabetes mellitus (DM), commonly referred to as diabetes, is a group of metabolic disorders in which there are high blood sugar levels over a prolonged period. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger. If left untreated, diabetes can cause many complications. Acute complications can include diabetic ketoacidosis, hyperosmolar hyperglycemic state, or death. Serious long-term complications include cardiovascular disease, stroke, chronic kidney disease, foot ulcers, and damage to the eyes.Diabetes is due to either the pancreas not producing enough insulin, or the cells of the body not responding properly to the insulin produced. There are three main types of diabetes mellitus:
Type 1 DM results from the pancreas' failure to produce enough insulin due to loss of beta cells. This form was previously referred to as "insulin-dependent diabetes mellitus" (IDDM) or "juvenile diabetes". The cause is unknown.
Type 2 DM begins with insulin resistance, a condition in which cells fail to respond to insulin properly. As the disease progresses, a lack of insulin may also develop. This form was previously referred to as "non insulin-dependent diabetes mellitus" (NIDDM) or "adult-onset diabetes". The most common cause is a combination of excessive body weight and insufficient exercise.
Gestational diabetes is the third main form, and occurs when pregnant women without a previous history of diabetes develop high blood sugar levels.Prevention and treatment involve maintaining a healthy diet, regular physical exercise, a normal body weight, and avoiding use of tobacco. Control of blood pressure and maintaining proper foot care are important for people with the disease. Type 1 DM must be managed with insulin injections. Type 2 DM may be treated with medications with or without insulin. Insulin and some oral medications can cause low blood sugar. Weight loss surgery in those with obesity is sometimes an effective measure in those with type 2 DM. Gestational diabetes usually resolves after the birth of the baby.As of 2015, an estimated 415 million people had diabetes worldwide, with type 2 DM making up about 90% of the cases. This represents 8.3% of the adult population, with equal rates in both women and men. As of 2014, trends suggested the rate would continue to rise. Diabetes at least doubles a person's risk of early death. From 2012 to 2015, approximately 1.5 to 5.0 million deaths each year resulted from diabetes. The global economic cost of diabetes in 2014 was estimated to be US$612 billion. In the United States, diabetes cost $245 billion in 2012.

Browse All Tags